BSE filing, NSE: RUBRAME. Summary written from the filing by ALFA Finder's alert engine.
Centuple Global Ltd: key numbers
- Share price
- ₹35.70
- Market cap
- ₹19.52 Cr
- Revenue (annual)
- ₹573.8 Cr
- Net profit (annual)
- ₹1.51 Cr
- P/E (TTM)
- 15.8×Sector 46.1×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 19.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Centuple Global Ltd
All →Centuple Global Annual General Meeting
Centuple Global Limited issued a Postal Ballot Notice seeking shareholder approval for the appointment of statutory auditors and a change in director's designation.
Centuple Global Other Announcement
Centuple Global Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Centuple Global Management Change
Centuple Global Limited appointed a new Statutory Auditor and designated Mr. Ajay Kumar Agarwal as the Whole-time Director.
Centuple Global Annual General Meeting
Centuple Global Limited conducted its 35th Annual General Meeting on September 30, 2026. Shareholders considered the adoption of audited financial statements and the appointment of an Independent Director.
Centuple Global Management Change
Centuple Global appointed Ajay Agarwal as additional Whole Time Director, subject to EGM approval. The 30-year FMCG and dairy specialist brings commercial and strategic leadership to the board.
Centuple Global Board Meeting Date
Centuple Global Limited scheduled a board meeting on September 24, 2026, to consider appointing a new Whole-Time Director.
Other board meeting date announcements
All →Indowind Energy Board Meeting Date
Indowind Energy scheduled a board meeting on 5 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-approval.
Dhunseri Ventures Board Meeting Date
Dhunseri Ventures Ltd intimated that its Board will meet on 6 November 2026, inter alia to approve Q2 FY27 results. The trading window stays closed until 8 November 2026.
CESC Board Meeting Date
CESC Ltd scheduled its Board Meeting for 5 Nov 2026 to consider Q2/H1 FY27 unaudited results. No financial figures or decisions are reported in this advance intimation.
Genpharmasec Board Meeting Date
Genpharmasec Ltd will hold a Board meeting on 03 Nov 2026. Agenda includes proposing approval of Q2/H1 FY27 unaudited results.
Hexa Tradex Board Meeting Date
Hexa Tradex scheduled its board meeting for November 5, 2026, to approve Q2 FY27 unaudited financial results. Trading window closes until 48 hours post-disclosure.
Ampvolts Board Meeting Date
Ampvolts Ltd has scheduled its Board meeting for November 6, 2026, to approve unaudited Q2/H1 FY27 results. No financial figures are disclosed in this prior intimation.